笨拙的你
发表于 2025-3-26 21:30:33
http://reply.papertrans.cn/20/1906/190561/190561_31.png
任命
发表于 2025-3-27 03:24:19
Genders and Sexualities in Historythe diagnosis of epithelial malignancies (2). UCD/PR 10.11 reacts with CK 8 and 18. It has a superb signal-to-noise ratio in staining almost all simple epithelia and is thought by some to be one of the best diagnostic monoclonal anti-keratin available for immunopathology (3). It is now commercially available through Triton Biosciences, Inc.
遗弃
发表于 2025-3-27 09:01:55
http://reply.papertrans.cn/20/1906/190561/190561_33.png
流出
发表于 2025-3-27 12:21:53
Testicular Heat Stress and Sperm Qualityn with endocrine therapy.. Criteria for the selection of patients that will respond to hormonal treatment have been the subject of intense study during the last 2 decades.. On the molecular level this had led to the development of analytical tools for the study of steroid receptors and steroid-induced proteins.
octogenarian
发表于 2025-3-27 14:36:22
http://reply.papertrans.cn/20/1906/190561/190561_35.png
绝种
发表于 2025-3-27 18:57:05
http://reply.papertrans.cn/20/1906/190561/190561_36.png
空中
发表于 2025-3-28 00:28:43
http://reply.papertrans.cn/20/1906/190561/190561_37.png
Decrepit
发表于 2025-3-28 02:45:51
http://reply.papertrans.cn/20/1906/190561/190561_38.png
Surgeon
发表于 2025-3-28 08:57:00
Complementation of Monoclonal Antibodies DF3 and B72. 3 in Reactivity to Breast Cancerngerprint” cell populations. The utilization of antibodies as immunologic probes to detect and phenotype cell populations in tissue preparations have moved rapidly from the research area to the clinical application. The MAbs are also increasingly being utilized in serum assays to detect circulating TAAs in patients with breast carcinoma.
Evocative
发表于 2025-3-28 11:08:06
Cell Heterogeneity and Complexity of Breast Epithelial Surface Antigens Expression and Moab Therapyect of the latter that must be taken into consideration is the complexity and cell heterogeneity in expression of most antigens that have an appropriate tissue or tumor cell specificity for therapy. This paper will address the question of antigenic heterogeneity in approaching the use of monoclonal antibodies for therapy of breast cancer.